RRBI · Red River Bancshares Inc

Reflects 800 shares of unvested restricted stock granted to the reporting person on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Includes 2,900 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 240 shares vest on July 1, 2026; (ii) 720 shares vest on April 1, 2027; (iii) 140 shares vest on July 1, 2027; (iv) 720 shares vest on April 1, 2028; (v) 560 shares vest on April 1, 2029; (vi) 360 shares vest on April 1, 2030; and (vii) 160 shares vest on April 1, 2031. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 600 shares of unvested restricted stock granted to the reporting person on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Includes 2,330 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 150 shares vest on July 1, 2026; (ii) 680 shares vest on April 1, 2027; (iii) 680 shares vest on April 1, 2028; (iv) 480 shares vest on April 1, 2029; (v) 220 shares vest on April 1, 2030; and (vi) 120 shares vest on April 1, 2031. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 800 shares of unvested restricted stock granted to the reporting person on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 800 shares of unvested restricted stock granted to the reporting person's spouse, Tammi R. Salazar, on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Held directly by the reporting person's spouse, Tammi R. Salazar. Includes 2,900 shares of unvested restricted stock granted to the reporting person's spouse which vest as follows: (i) 240 shares vest on July 1, 2026; (ii) 720 shares vest on April 1, 2027; (iii) 140 shares vest on July 1, 2027; (iv) 720 shares vest on April 1, 2028; (v) 560 shares vest on April 1, 2029; (vi) 360 shares vest on April 1, 2030; and (vii) 160 shares vest on April 1, 2031. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 800 shares of unvested restricted stock granted to the reporting person on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Consists of 38,270 shares held in a joint account with the reporting person's spouse, Tammi R. Salazar, and 4,800 shares held directly by the reporting person. Includes 2,900 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 240 shares vest on July 1, 2026; (ii) 720 shares vest on April 1, 2027; (iii) 140 shares vest on July 1, 2027; (iv) 720 shares vest on April 1, 2028; (v) 560 shares vest on April 1, 2029; (vi) 360 shares vest on April 1, 2030; and (vii) 160 shares vest on April 1, 2031. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 800 shares of unvested restricted stock granted to the reporting person's spouse, Bryon C. Salazar, on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Held directly by the reporting person's spouse, Bryon C. Salazar. Includes 2,900 shares of unvested restricted stock granted to the reporting person's spouse which vest as follows: (i) 240 shares vest on July 1, 2026; (ii) 720 shares vest on April 1, 2027; (iii) 140 shares vest on July 1, 2027; (iv) 720 shares vest on April 1, 2028; (v) 560 shares vest on April 1, 2029; (vi) 360 shares vest on April 1, 2030; and (vii) 160 shares vest on April 1, 2031. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 800 shares of unvested restricted stock granted to the reporting person on April 1, 2026 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Consists of 38,270 shares held in a joint account with the reporting person's spouse, Bryon C. Salazar, and 4,800 shares held directly by the reporting person. Includes 2,900 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 240 shares vest on July 1, 2026; (ii) 720 shares vest on April 1, 2027; (iii) 140 shares vest on July 1, 2027; (iv) 720 shares vest on April 1, 2028; (v) 560 shares vest on April 1, 2029; (vi) 360 shares vest on April 1, 2030; and (vii) 160 shares vest on April 1, 2031. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Consists of 38,270 shares held in a joint account with the reporting person's spouse, Tammi R. Salazar, and 4,000 shares held directly by the reporting person. Includes 2,660 shares of unvested restricted stock granted to the reporting person, which vest as follows: (i) 560 shares vest on April 1, 2026; (ii) 240 shares vest on July 1, 2026; (iii) 560 shares vest on April 1, 2027; (iv) 140 shares vest on July 1, 2027; (v) 560 shares vest on April 1, 2028; (vi) 400 shares vest on April 1, 2029; and (vii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant. The number of shares reported reflects a prior change in the form of beneficial ownership.

Consists of 38,270 shares held in a joint account with the reporting person's spouse, Bryon C. Salazar, and 4,000 shares held directly by the reporting person. Includes 2,660 shares of unvested restricted stock granted to the reporting person, which vest as follows: (i) 560 shares vest on April 1, 2026; (ii) 240 shares vest on July 1, 2026; (iii) 560 shares vest on April 1, 2027; (iv) 140 shares vest on July 1, 2027; (v) 560 shares vest on April 1, 2028; (vi) 400 shares vest on April 1, 2029; and (vii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant. The number of shares reported reflects a prior change in the form of beneficial ownership.

This transaction was executed in multiple trades at prices ranging from $90.09 to $90.56, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2025. The price as shown above reflects the closing sales price of the common stock on the transaction date.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2025. The price as shown above reflects the closing sales price of the common stock on the transaction date.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2025. The price as shown above reflects the closing sales price of the common stock on the transaction date.

Includes 16,500 shares previously reported as held in an estate that are now directly held as a result of settlement of the estate.

This transaction was executed in multiple trades at prices ranging from $59.87 to $60.51, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Includes 16,500 shares held in an estate account for which Mr. Price serves as executor. Mr. Price is expected to receive ownership of these shares once the estate is settled.

Reflects 1,000 shares of unvested restricted stock granted to the reporting person's spouse, Tammi R. Salazar, on April 1, 2025 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Held directly by the reporting person's spouse, Tammi R. Salazar. Includes 3,020 shares of unvested restricted stock granted to the reporting person's spouse which vest as follows: (i) 360 shares vest on July 1, 2025; (ii) 560 shares vest on April 1, 2026; (iii) 240 shares vest on July 1, 2026; (iv) 560 shares vest on April 1, 2027; (v) 140 shares vest on July 1, 2027; (vi) 560 shares vest on April 1, 2028; (vii) 400 shares vest on April 1, 2029; and (viii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant. The number of shares reported reflects a prior change in the form of beneficial ownership.

Reflects 1,000 shares of unvested restricted stock granted to the reporting person on April 1, 2025 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Includes 3,020 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 360 shares vest on July 1, 2025; (ii) 560 shares vest on April 1, 2026; (iii) 240 shares vest on July 1, 2026; (iv) 560 shares vest on April 1, 2027; (v) 140 shares vest on July 1, 2027; (vi) 560 shares vest on April 1, 2028; (vii) 400 shares vest on April 1, 2029; and (viii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 500 shares of unvested restricted stock granted to the reporting person on April 1, 2025 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Includes 2,440 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 150 shares vest on July 1, 2025; (ii) 560 shares vest on April 1, 2026; (iii) 150 shares vest on July 1, 2026; (iv) 560 shares vest on April 1, 2027; (v) 560 shares vest on April 1, 2028; (vi) 360 shares vest on April 1, 2029; and (vii) 100 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Reflects 1,000 shares of unvested restricted stock granted to the reporting person on April 1, 2025 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Consists of 37,235 shares held in a joint account with the person's spouse, Tammi R. Salazar, and 4,600 shares held directly by the reporting person. Includes 3,020 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 360 shares vest on July 1, 2025; (ii) 560 shares vest on April 1, 2026; (iii) 240 shares vest on July 1, 2026; (iv) 560 shares vest on April 1, 2027; (v) 140 shares vest on July 1, 2027; (vi) 560 shares vest on April 1, 2028; (vii) 400 shares vest on April 1, 2029; and (viii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant. The number of shares reported reflects a prior change in the form of beneficial ownership.

Reflects 1,000 shares of unvested restricted stock granted to the reporting person on April 1, 2025 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Consists of 37,325 shares held in a joint account with the reporting person's spouse, Bryon C. Salazar, and 4,600 shares held directly by the reporting person. Includes 3,020 shares of unvested restricted stock granted to the reporting person which vest as follows: (i) 360 shares vest on July 1, 2025; (ii) 560 shares vest on April 1, 2026; (iii) 240 shares vest on July 1, 2026; (iv) 560 shares vest on April 1, 2027; (v) 140 shares vest on July 1, 2027; (vi) 560 shares vest on April 1, 2028; (vii) 400 shares vest on April 1, 2029; and (viii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant. The number of shares reported reflects a prior change in the form of beneficial ownership.

Reflects 1,000 shares of unvested restricted stock granted to the reporting person's spouse, Bryon C. Salazar, on April 1, 2025 that will vest in equal installments on each of the first five anniversaries of the grant date. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.

Held directly by the reporting person's spouse, Bryon C. Salazar. Includes 3,020 shares of unvested restricted stock granted to the reporting person's spouse which vest as follows: (i) 360 shares vest on July 1, 2025; (ii) 560 shares vest on April 1, 2026; (iii) 240 shares vest on July 1, 2026; (iv) 560 shares vest on April 1, 2027; (v) 140 shares vest on July 1, 2027; (vi) 560 shares vest on April 1, 2028; (vii) 400 shares vest on April 1, 2029; and (viii) 200 shares vest on April 1, 2030. The reported shares of unvested restricted stock are subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant. The number of shares reported reflects a prior change in the form of beneficial ownership.

Includes 16,500 shares held in an estate account for which Mr. Price serves as executor. Mr. Price is expected to receive ownership of these shares once the estate is settled.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2024. The price as shown above reflects the closing sales price of the common stock on the transaction date.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2024. The price as shown above reflects the closing sales price of the common stock on the transaction date.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2024. The price as shown above reflects the closing sales price of the common stock on the transaction date.

Includes 16,500 shares held in an estate for which Mr. Price serves as executor. Mr. Price is expected to receive ownership of these shares once the estate is settled.

This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2024. The price as shown above reflects the closing sales price of the common stock on the transaction date.

This transaction was executed in multiple trades at prices ranging from $52.668 to $52.777, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Includes 16,500 shares held in an estate for which Mr. Price serves as executor. Mr. Price is expected to receive ownership of these shares once the estate is settled.

Includes 16,500 shares held in an estate for which Mr. Price serves as executor. Mr. Price is expected to receive ownership of these shares once the estate is settled.